Holst Centre and Philips Research Celebrate Successful Collaboration

PhilipsSince 2005, Philips Research and a growing amount (35) of other industrial partners combine their innovation power at Holst Centre, an open-innovation initiative by imec (B) and TNO (NL), to take technology in the areas of wireless sensors and flexible electronics to the next level. In over 5 years, scientists achieved substantial scientific progress, resulting in several technology breakthroughs. Philips Research was co-author of over 20 of Holst Centre's patent filings and more than 100 technical notes. Recent successes like the first large-area (30x30cm2) flexible OLED lighting device (developed in the EU project Fast2light), the novel wireless EEG sensing technology and a power conditioning circuit for miniaturized sensors encouraged Holst Centre and Philips Research to prolong their existing collaboration agreement until the end of 2015.

The realization of a large 30x30cm2 flexible OLED is a major step towards substantially thinner and flexible OLEDs. Up to now, OLEDs are made of glass substrates and encapsulated between two layers of glass to protect them from external factors like moisture. In the flexible electronics program at Holst Centre, researchers are working towards replacing both the glass substrate and the encapsulation with flexible foils and thin film layers. This will enable significant reduction of the production costs of OLEDs because the usage of flexible foils enables high speed roll-to-roll fabrication. Thinner and flexible, lightweight OLEDs pave the way towards letting any object in houses or offices emit light, or even customized light patterns.

In the program on wireless sensor technologies, the joint efforts of Philips, Holst Centre and several other partners resulted in a cutting edge sensing technology. With a device that has the look and feel of a regular headphone, consumers will be able to easily measure brain activity (EEG, electro encephalogram) without any special measures. The innovative 'dry' sensor eliminates the use of conductive gel, opening up various consumer application opportunities. Philips is currently looking into applications that coach people towards their optimal state of relaxation.

Also, an autonomous inductive boost converter for indoor photovoltaic energy conversion was jointly achieved. The power management chip is, suitable for miniaturized self-powered sensors. The innovative circuit can efficiently charge a battery or super capacitor even in the presence of very low incident light levels.

"The collaboration output has proven to be most relevant; already several technologies are embedded in either Philips Research or one of the Philips sectors. All the more reason to continue to together drive innovation." states Henk van Houten, General Manager Philips Research.

Jaap Lombaers and Bert Gyselinckx, General Managers at Holst Centre: "As a partner from the first hour on, Philips Research has had a major stake in Holst Centre's rapid evolution in the past five years. We're very proud that some of our technologies now are on their way towards implementation in Philips products. After all, enabling useful implementation by our industrial partners of new, jointly developed technologies is Holst Centre's reason for being."

The Holst Centre open innovation business model - based on the successful way of working used by imec - is at the base of the economical and technological progress made over the past years. By bringing together industrial partners from across the value chain (materials suppliers, equipment manufacturers and end users), complementary knowledge is brought together in the Holst Centre programs. This allows participating companies to speed up their innovation and share costs and risks of R&D.

Related news articles:

About Royal Philips Electronics
Royal Philips Electronics of the Netherlands (NYSE: PHG, AEX: PHI) is a diversified health and well-being company, focused on improving people's lives through timely innovations. As a world leader in healthcare, lifestyle and lighting, Philips integrates technologies and design into people-centric solutions, based on fundamental customer insights and the brand promise of "sense and simplicity." Headquartered in the Netherlands, Philips employs over 120,000 employees with sales and services in more than 100 countries worldwide. With sales of EUR 22.3 billion in 2010, the company is a market leader in cardiac care, acute care and home healthcare, energy efficient lighting solutions and new lighting applications, as well as lifestyle products for personal well-being and pleasure with strong leadership positions in male shaving and grooming, portable entertainment and oral healthcare.

About Holst Centre
Holst Centre is an independent open-innovation R&D centre that develops generic technologies for Wireless Autonomous Sensor Technologies and for Flexible Electronics. A key feature of Holst Centre is its partnership model with industry and academia around shared roadmaps and programs. It is this kind of cross-fertilization that enables Holst Centre to tune its scientific strategy to industrial needs. Holst Centre was set up in 2005 by imec (Flanders, Belgium) and TNO (The Netherlands) with support from the Dutch Ministry of Economic Affairs and the Government of Flanders. It is named after Gilles Holst, a Dutch pioneer in Research and Development and first director of Philips Research. Located on High Tech Campus Eindhoven, Holst Centre benefits from the state-of-the-art on-site facilities. Holst Centre has over 170 employees from 28 nationalities and a commitment from over 30 industrial partners.

Most Popular Now

Herefordshire and Worcestershire Health …

Herefordshire and Worcestershire Health and Care NHS Trust has successfully implemented Alcidion's Miya Precision platform to streamline bed management workflow across seven community hospitals in Worcestershire. The trust delivers community...

With Huge Patient Dataset, AI Accurately…

Scientists have designed a new artificial intelligence (AI) model that emulates randomized clinical trials at determining the treatment options most effective at preventing stroke in people with heart disease. The model...

A Shortcut for Drug Discovery

For most human proteins, there are no small molecules known to bind them chemically (so called "ligands"). Ligands frequently represent important starting points for drug development but this knowledge gap...

New Horizon Europe Funding Boosts Europe…

The European Commission has announced the launch of new Horizon Europe calls, with a substantial funding pool of over €112 million. These calls are aimed primarily at pioneering projects in...

Cleveland Clinic Study Finds AI can Deve…

Cleveland Clinic researchers developed an artficial intelligence (AI) model that can determine the best combination and timeline to use when prescribing drugs to treat a bacterial infection, based solely on...

New AI-Technology Estimates Brain Age Us…

As people age, their brains do, too. But if a brain ages prematurely, there is potential for age-related diseases such as mild-cognitive impairment, dementia, or Parkinson's disease. If "brain age...

Radboud University Medical Center and Ph…

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and Radboud University Medical Center have signed a hospital-wide, long-term strategic partnership that delivers the latest patient monitoring...

GPT-4, Google Gemini Fall Short in Breas…

Use of publicly available large language models (LLMs) resulted in changes in breast imaging reports classification that could have a negative effect on patient management, according to a new international...

ChatGPT fails at heart risk assessment

Despite ChatGPT's reported ability to pass medical exams, new research indicates it would be unwise to rely on it for some health assessments, such as whether a patient with chest...

Study Shows ChatGPT Failed when Challeng…

With artificial intelligence (AI) poised to become a fundamental part of clinical research and decision making, many still question the accuracy of ChatGPT, a sophisticated AI language model, to support...

Virtual Reality Shows Promise in Fightin…

A new study published in JMIR Mental Health sheds light on the promising role of virtual reality (VR) in treating major depressive disorder (MDD). Titled "Examining the Efficacy of Extended...

AXREM and Highland Marketing Partner to …

AXREM represents member companies that collectively provide UK hospitals with most of their diagnostic medical imaging technology, and radiotherapy equipment. The association has seen substantial growth in recent years, with membership...